Advances and challenges in the purification of recombinant coagulation factors: A review

凝结 重组DNA 化学 止血 生化工程 生物技术 风险分析(工程) 生物 医学 生物化学 工程类 外科 基因 精神科
作者
Linling Yu,Dongmei Yang,M.C. Chu,Yan Sun
出处
期刊:Journal of Chromatography A [Elsevier BV]
卷期号:1716: 464662-464662 被引量:1
标识
DOI:10.1016/j.chroma.2024.464662
摘要

Hemostasis is a complex process for the cessation of bleeding from an injured blood vessel, involving the interplay of 12 coagulation factors in the coagulation cascade with activated blood platelets and the vessel wall. Hence, the coagulation factors are important to control hemorrhage. However, the low abundance of many coagulation factors in human plasma proteins limited their production in therapeutic drugs and their clinical applications. With the development of modern biotechnology, commercially manufactured recombinant coagulation factors became available as hemostatic therapeutics, emerging a huge potential in pharmaceutical manufacturing market. Unlike antibodies, whose standard operation unit or platform purification processes in the industrial-scale downstream processing has been well-established, the complexity in post-translational modification and differences in structures of the coagulation factors posed specific challenges with respect to the downstream processing, which have long been limiting their industrial-scale production. This review presents a comprehensive overview of the technological development of commercially manufactured recombinant coagulation factors, with emphasis on their advances and challenges in the separation and purification processes. Firstly, the licensed products of the plasma derived and recombinant coagulation factors are summarized. Then, typical recombinant coagulation factors, i.e. factors VII, VIII and IX, are introduced with detailed discussion on their preparative separation procedures for both the licensed products of industrial-scale and the experimental cases of laboratory-scale. Finally, perspectives and challenges in the future development of the purification technology of recombinant coagulation factors are highlighted to provide new insight into the design of cost-effective purification processes of recombinant coagulation factors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被玉米侠采纳,获得10
2秒前
razor发布了新的文献求助30
3秒前
4秒前
zyl666完成签到,获得积分10
5秒前
zlx完成签到,获得积分10
5秒前
风吹麦浪的应助被整齐冬菱采纳,获得10
7秒前
顾矜的应助被alvin采纳,获得10
8秒前
田様的应助被帅气的惜天采纳,获得10
8秒前
8秒前
852的应助被熊98采纳,获得10
9秒前
11秒前
yiying完成签到 ,获得积分10
13秒前
搜集达人的应助被DXL采纳,获得10
13秒前
14秒前
紫垣完成签到,获得积分10
14秒前
15秒前
15秒前
披萨好吃酱完成签到,获得积分10
15秒前
chestnut灬完成签到,获得积分10
15秒前
alvin对应助文件撤销了驳回
15秒前
16秒前
16秒前
李希完成签到,获得积分10
16秒前
zzz1完成签到,获得积分10
16秒前
单纯英姑发布了新的文献求助10
16秒前
Fllipped完成签到 ,获得积分10
17秒前
17秒前
可爱的函函的应助被洁净雅彤采纳,获得10
18秒前
拉长的南松完成签到 ,获得积分10
19秒前
熊98发布了新的文献求助10
20秒前
libra完成签到 ,获得积分10
20秒前
CodeCraft的应助被夙夙采纳,获得10
20秒前
玉米侠发布了新的文献求助10
20秒前
yifei完成签到,获得积分10
22秒前
爆米花的应助被予安采纳,获得30
22秒前
wanci的应助被迟安歌采纳,获得10
23秒前
younger发布了新的文献求助10
23秒前
24秒前
25秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188563
求助须知:如何正确求助?哪些是违规求助? 9576328
关于积分的说明 21846521
捐赠科研通 7786563
什么是DOI,文献DOI怎么找? 3435354
关于科研通互助平台的介绍 2559627
邀请新用户注册赠送积分活动 2482336